GlaxoSmithKline has agreed to pay $3 billion to resolve federal investigations into the marketing of some of its drugs, including the controversial type 2 diabetes drug, Avandia. According to a report from Bloomberg News, the agreement with the U.S. Department of Justice would constitute Glaxo’s biggest legal settlement so far. Negotiations to finalize the Glaxo settlement should be completed next year.

• The Construction & Operation of Clandestine Drug Laboratories
  

  The Construction & Operation of Clandestine Drug Laborato...

  The Construction & Operation of Clandestine Drug Laboratories drug design – click on the image...

  Read Full Story »
• California Avandia Lawyers
  

  California Avandia Lawyers

  The first sign of serious side effects was admitted by GlaxoSmithKline way back in...

  Read Full Story »
• Avandia is a type2 anti-diabetic drug
  

  Avandia is a type2 anti-diabetic drug

  Article by Mike Bordon Avandia is used as an anti-diabetic medication...

  Read Full Story »
• I want to know what is in the drug that the FDA recalled it is called DIGITEC or digoxin?
  

  I want to know what is in the drug that the FDA recalled ...

  by Coal and Ice I want to know what is in the drug that the FDA re called it is called DIGITEC...

  Read Full Story »
• GlaxoSmithKline settles U.S. drug rows for $3 billion
  GlaxoSmithKline settles U.S. drug rows for $3 billion

  LONDON ( Reuters ) - GlaxoSmithKline Plc has agreed in principle to settle several long-standing disputes with the U.S. government over the way it marketed and developed drugs, at a cost of $3...

  Read Full Story »